William A. Heyburn - 09 Dec 2025 Form 4 Insider Report for Strata Critical Medical, Inc. (BLDE)

Role: Co-CEO and CFO, Director
Signature: /s/ Melissa M. Tomkiel, as attorney-in-fact for William A. Heyburn
Issuer symbol: BLDE
Transactions as of: 09 Dec 2025
Net transactions value: +$76,044
Form type: 4
Filing time: 10 Dec 2025, 16:15:25 UTC
Previous filing: 05 Nov 2025
Next filing: 12 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Heyburn William A.	Co-CEO and CFO, Director	C/O STRATA CRITICAL MEDICAL, INC., 31 HUDSON YARDS, 14TH FLOOR, NEW YORK	/s/ Melissa M. Tomkiel, as attorney-in-fact for William A. Heyburn	10 Dec 2025	0001859732

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRTA	Class A common stock, $0.0001 par value per share	Purchase	$76,044	+17,000	+1.2%	$4.47	1,403,436	09 Dec 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person realized short-swing profits under Section 16(b) of the Exchange Act as a result of transactions reported on this Form 4. On December 10, 2025, the reporting person disgorged to the Issuer the Section 16(b) short-swing profits realized by the reporting person from such transactions.
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.45 to $4.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.

Content

The reporting person realized short-swing profits under Section 16(b) of the Exchange Act as a result of transactions reported on this Form 4. On December 10, 2025, the reporting person disgorged to the Issuer the Section 16(b) short-swing profits realized by the reporting person from such transactions.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.45 to $4.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.